Searched for
OXFORD STUDY ON COVID
Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- Anthropic policy chief Jack Clark says, “AI will help make a Nobel prize-winning discovery within a year.”AI is rapidly evolving beyond a search engine, with predictions of Nobel Prize-winning scientific discoveries and AI-staffed companies with...
- Why travellers are turning to the zodiac for vacation planningPeople are increasingly using astrocartography to guide major life choices. This practice, which maps planetary influences on locations, he...
- Trouble focusing after Covid? Oxford study finds that even after mild infection your brain may shrink, rewire or get damagedThese changes have been observed after several months of the Covid infection.
- Oxford scientists to study effects of Covid variants, complications of shots during pregnancyThe upcoming British study will enroll about 1,500 women who have tested positive for the virus at any stage of pregnancy.
- Lung abnormalities found in long COVID patients with breathlessnessResearchers used a novel xenon gas scan method to pick up lung abnormalities in coronavirus patients who have not been hospitalised but sti...
- COVID antiviral Molnupiravir to be tested in RECOVERY trial on hospitalised patientsThe RECOVERY Trial was launched as an emergency response in March 2020 and has so far discovered three effective treatments for COVID-19 - ...
- AstraZeneca vaccine booster shot effective against Omicron: Oxford lab studyThe Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the v...
- COVID-19 bigger blood clot threat than vaccines, UK study findsThe findings showed although there was an increased risk of having a blood clot after having the first doses of either vaccine, it was much...
- Worried about vaccine side-effects? Oxford-led study says Covid can lead to higher blood clot riskThe blood clots events have led to restricted use of Covishield in a number of countries.
- Oxford COVID vaccine produces strong immune response from booster shot: StudyThe Oxford University study found that a third dose of the vaccine increases antibody and T-cell immune responses, while the second dose ca...
- UK scientists find higher risk of brain clots from COVID-19 compared with vaccinesA study of 500,000 COVID-19 patients found CVST had occurred at a rate of 39 people out of a million following infection, researchers said....
- Neurological and mental disorders major risks for Covid patients, finds Oxford studyThe most common diagnoses after Covid were anxiety disorders.
- Oxford study indicates AstraZeneca effective against Brazil variant, source saysThe data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have origina...
- Pfizer, Oxford vaccines reduce severe COVID-19 in elderly, study findsThe research, posted as a pre-print and yet to be peer-reviewed, estimated the effect of both the COVID-19 vaccines on laboratory confirmed...
- Single dose of Pfizer and Astrazeneca Covid vaccines highly effective: StudiesIsraeli studies have found the Pfizer vaccine to be 95 percent effective one week after a second jab, while the Lancet report focused on mo...
- Oxford/AstraZeneca first jab cuts COVID transmission substantially: UK studyThe UK government described this as good news for the world because the impact of COVID vaccines on transmission has been a crucial unknown...
- Hospitalised COVID-19 patients can have ongoing symptoms for months: Oxford studyThe scientists also detected abnormalities in multiple organs and believe persistent inflammation may be a factor for COVID-19 survivors, t...
Load More
